Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04328103 · ClinicalTrials.gov registry record
Mechanisms of Emotion Regulation Underlying Successful CBT in Depression
A clinical trial of Major Depressive Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT04328103 is a study of Major Depressive Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 41 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04328103, a study of Major Depressive Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to elucidate mechanisms through which change occurs during cognitive behavior therapy (CBT) for depression. Assessing meta-cognitive processes of self-knowledge (top-down), electrophysiological and behavioral correlates of emotion processing (bottom-up), and their relation to treatment outcome will provide new insights into the mechanisms of emotion regulation deficits in depression. It will also contribute toward the clinical goal of identifying patients who may benefit most from CBT for unipolar depression.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavior Therapy (CBT)
- BEHAVIORAL Nonspecific Supportive Therapy (PBO)
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2023-06-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04328103
The ClinicalTrials.gov registry entry for NCT04328103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (89% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavior Therapy (CBT) is the first listed.
NCT04328103 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04328103 about?
NCT04328103 is a clinical study titled "Mechanisms of Emotion Regulation Underlying Successful CBT in Depression". This research aims to elucidate mechanisms through which change occurs during cognitive behavior therapy (CBT) for depression. Assessing meta-cognitive processes of self-knowledge (top-down), electrophysiological and behavioral correlates of emotion processing (bottom-up), and their relation to trea...
What is the current status of trial NCT04328103?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2020-11-25. Estimated completion is 2023-06-02.
What conditions does trial NCT04328103 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT04328103?
The interventions under investigation include: Cognitive Behavior Therapy (CBT) (BEHAVIORAL), Nonspecific Supportive Therapy (PBO) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04328103?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04328103 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Taking Action for College Students
RECRUITING · NA
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.